对自然存在的阿波利波蛋白E变体的结构和功能洞察,具有对阿尔茨海默病的保护作用
Daphne Georgiadou1, Angeliki Chroni1
1Institute of Biosciences and Applications, National Center for Scientific Research "Demokritos", Agia Paraskevi, Athens, Greece.
International journal of biological macromolecules
|December 13, 2025
概括
罕见的阿波利波蛋白E (apoE) 变体提供了对阿尔茨海默氏病 (AD) 的保护. 这些变异改变了apoE结构和稳定性,增强了神经元活力,减少了炎症,独立于apoE背景.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 遗传学 遗传学 是一个
背景情况:
- 脂蛋白E (apoE) 对于脂质运输至关重要.
- APOE4是晚期阿尔茨海默病 (AD) 的重要遗传风险因素.
- 罕见的apoE变种显示出对AD的保护作用,但它们的分子基础尚不清楚.
研究的目的:
- 研究保护性apoE变体的结构和热力学基础.
- 为了比较罕见的apoE变体与野生类型的apoE3和apoE4.4的完整性.
主要方法:
- 循环二重化谱法用于分析二次结构.
- 化学和热化以评估蛋白质的展开和稳定性.
- 在脂化后进行细胞活力测定 (SK-N-SH神经母细胞瘤) 和炎症标志物分析 (BV2微质中的TNFα).
主要成果:
- 这种V236E变种改变了二次结构,并减少了无脂的apoE中的寡合化.
- V236E和R251G变种显示出改变的展开配置文件.
- 所有的保护变体在与脂蛋白结合时都表现出热力学稳定.
- 脂质保护性apoE变体增强了神经母细胞细胞活力,并减少了微质TNFα的产生.
结论:
- 保护性apoE变体中的特定氨基酸替代改变了分子稳定性和构造.
- 这些结构变化导致了对AD有益的功能后果,包括改善神经元健康和减少神经炎症.
- 保护作用独立于底层的apoE异型 (E3或E4).
更多相关视频
09:33Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
8.3K
09:37Optimized Negative Staining: a High-throughput Protocol for Examining Small and Asymmetric Protein Structure by Electron Microscopy
Published on: August 15, 2014
44.7K
相关概念视频
01:26Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
03:03Amyloid Fibrils
11.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.5K
01:22Alzheimer's Disease: Treatment
752
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
752